Satellogic Reports Full Year 2022 Financial Results and Provides Business Update
Revenue up
Largest Sub-Meter Resolution Commercial Capture Capability (7MM+ sq km daily) in the World; Expanded Fleet to 34 Satellites in Orbit
“2022 was a transformational year for
“During 2022, our revenue grew
“Our new Space Systems (satellite sales) business creates a satellite purchase program that aims to lower the financial barrier to Earth Observation spacecraft ownership. Purchase options begin at less than
“We have proven that it's possible to provide high-quality satellite imagery through a constellation of small, low-orbit satellites at what we believe to be the lowest price while retaining strong margins. We expect to build and launch 14 additional satellites, which will give us the capability of remapping the Earth every two weeks by the end of 2023.”
“Going forward, revenue will be driven by our continued growth in Asset Monitoring, Constellation-as-a-Service, and sales of Space Systems. We anticipate that Space Systems will contribute considerable per unit cash flow and strong gross margin,” concluded Dunn.
Financial Results for the Year Ended
-
Revenue during the year ended
December 31, 2022 increased42% to , as compared to revenue of$6.0 million for the year ended$4.3 million December 31, 2021 . The increase was driven primarily by Asset Monitoring, with Constellation-as-a-Service gaining momentum following a multi-million-dollar agreement awarded from theRepublic of Albania . -
Gross margin during the year ended
December 31, 2022 increased15% to , as compared to a gross margin of$2.7 million for the year ended$2.4 million December 31, 2021 . Gross margin was45% during the year endedDecember 31, 2022 , as compared to56% for the year endedDecember 31, 2021 , due to higher ground station and cloud services costs associated with our larger constellation. -
General and administrative expenses were
during the year ended$37.2 million December 31, 2022 , as compared to for the year ended$36.6 million December 31, 2021 . The slight increase was due to increased costs associated with being a public company, primarily insurance, partially offset by lower professional fees related to elevated going public costs in 2021, and lower stock-based compensation. -
Research & Development expenses increased to
for the year ended$13.1 million December 31, 2022 as compared to for the year ended$9.6 million December 31, 2021 . The increase was driven primarily by a higher average headcount in 2022 as compared to 2021, which contributed to an increase in stock-based compensation, salaries and wages, and other R&D expenses, such as software costs and laboratory supplies. -
Net loss for the year ended
December 31, 2022 decreased to , as compared to a net loss of$36.6 million for the year ended$96.3 million December 31, 2021 . The decrease was primarily driven by a change in fair value of financial instruments related to net gains of for the year ended$58.3 million December 31, 2022 , compared to net gains of for the year ended$18.0 million December 31, 2021 . The change was primarily driven by the remeasurement to fair value of our warrant and earnout liabilities issued in conjunction with the Merger. -
Adjusted EBITDA loss for the year ended
December 31, 2022 increased to from an Adjusted EBITDA loss of$56.0 million for the year ended$31.8 million December 31, 2021 due to increased costs associated with being a public company and higher average headcount in anticipation of business growth. -
Cash was
at$76.5 million December 31, 2022 , as compared to at$8.5 million December 31, 2021 . The increase in cash is due to the Merger, which resulted in the addition of approximately in cash.$168 million -
Net cash used in operating activities increased to
for the year ended$68.5 million December 31, 2022 , as compared to the year ended$28.4 million December 31, 2021 , primarily due to costs and expenses related to development of our products, payroll, fluctuations in accounts payable and other current assets and liabilities.
Key Second Half and Subsequent Highlights
- Established new Space Systems business line to sell satellites directly to select customers, with unmatched build-to-launch cycles as fast as three months.
-
Announced partnership and integration with SkyFi, a leading provider of EO data. This partnership will allow SkyFi’s customers to submit tasking orders to
Satellogic satellites directly through the platform either at https://app.skyfi.com or on the SkyFi app for both businesses and individuals. -
Executed a three-year agreement with the Government of
Albania to develop a dedicated satellite constellation with a Constellation-as-a-Service model to accelerate Albania’s participation in the New Space Economy and provide unprecedented, country-wide situational awareness. -
Deployed the “Albania-1” and “Albania-2” satellites that will support the
Republic of Albania pursuant to a recent 3-year Constellation-as-a-Service agreement entered into withSatellogic . The dedicated satellites will enableAlbania to task and monitor its sovereign territory for a range of applications including agriculture management, border security, and environmental monitoring. - Signed a letter of intent with Agencia Espacial Mexicana to develop a fully-featured and operational Constellation-as-a-Service program to monitor approximately 2 million square kilometers of the nation.
-
Completed a ~
5% investment inOfficina Stellare , a leader in the design and production of optomechanical instrumentation, driving strategic focus on vertical integration.
For additional information regarding our long-term outlook and risks and assumptions related thereto, see Item 5.B (Liquidity and Capital Resources) of Satellogic’s recent Form 20-F filing.
Use of Non-GAAP Financial Measures
To supplement our Consolidated Financial Statements, which are prepared and presented in accordance with
We define Non-GAAP EBITDA as net income (loss) excluding interest, income taxes, depreciation and amortization. We did not incur amortization expense during the years ended
We define Non-GAAP Adjusted EBITDA as Non-GAAP EBITDA further adjusted for merger-related transaction costs and other income (expense). Other income (expense) consists of foreign currency gains and losses, changes in the fair value of financial instruments and stock-based compensation.
We use these Non-GAAP financial measures for financial and operational decision-making and as a means to evaluate period-to-period comparisons. We believe these measures provide analysts, investors and management with helpful information regarding the underlying operating performance of our business, as they provide meaningful supplemental information regarding our performance and liquidity by removing the impact of items that we believe are not reflective of our underlying operating performance. The Non-GAAP measures are used by us to evaluate our core operating performance and liquidity on a comparable basis and to make strategic decisions. The Non-GAAP measures also facilitate company-to-company operating performance comparisons by backing out potential differences caused by variations such as capital structures, taxation, depreciation, capital expenditures and other non-cash items (i.e., embedded derivatives, debt extinguishment and stock-based compensation) which may vary for different companies for reasons unrelated to operating performance. However, different companies may define these terms differently and accordingly comparisons might not be accurate. There are a number of limitations related to the use of Non-GAAP financial measures. We compensate for these limitations by providing specific information regarding the
We have included reconciliations from the most directly comparable GAAP metric to Non-GAAP EBITDA and Non-GAAP Adjusted EBITDA for the years ended
The following table presents a reconciliation of Non-GAAP EBITDA and Non-GAAP Adjusted EBITDA to our net loss for the periods indicated.
|
Year Ended |
||||||||||
(in thousands of |
2022 |
|
2021 |
|
2020 |
||||||
Net loss |
$ |
(36,641 |
) |
|
$ |
(96,305 |
) |
|
$ |
(21,529 |
) |
Plus interest expense |
|
1,596 |
|
|
|
8,729 |
|
|
|
43 |
|
Plus income tax expense (benefit) |
|
4,573 |
|
|
|
(232 |
) |
|
|
148 |
|
Plus depreciation |
|
14,326 |
|
|
|
10,728 |
|
|
|
3,031 |
|
Non-GAAP EBITDA |
$ |
(16,146 |
) |
|
$ |
(77,080 |
) |
|
$ |
(18,307 |
) |
Plus Merger transaction costs |
|
11,188 |
|
|
|
16,236 |
|
|
|
— |
|
Less other income, net |
|
(1,140 |
) |
|
|
(1,069 |
) |
|
|
(594 |
) |
Less change in fair value of financial instruments |
|
(58,311 |
) |
|
|
(17,983 |
) |
|
|
(9,637 |
) |
Plus loss on extinguishment of debt |
|
— |
|
|
|
37,216 |
|
|
|
9,240 |
|
Plus stock-based compensation |
|
8,368 |
|
|
|
10,881 |
|
|
|
1,732 |
|
Non-GAAP Adjusted EBITDA |
$ |
(56,041 |
) |
|
$ |
(31,799 |
) |
|
$ |
(17,566 |
) |
About
Founded in 2010 by Emiliano Kargieman and
Satellogic’s mission is to democratize access to geospatial data through its information platform of high-resolution images to help solve the world’s most pressing problems including climate change, energy supply, and food security. Using its patented Earth imaging technology,
With more than a decade of experience in space,
To learn more, please visit: http://www.satellogic.com
Forward-Looking Statements
This press release contains “forward-looking statements” within the meaning of the
|
|||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS |
|||||||||||
|
Year Ended |
||||||||||
(in thousands of |
2022 |
|
2021 |
|
2020 |
||||||
Revenue |
$ |
6,012 |
|
|
$ |
4,247 |
|
|
$ |
— |
|
Costs and expenses |
|
|
|
|
|
||||||
Cost of sales, exclusive of depreciation shown separately below |
|
3,284 |
|
|
|
1,876 |
|
|
|
— |
|
General and administrative expenses |
|
37,191 |
|
|
|
36,640 |
|
|
|
8,003 |
|
Research and development |
|
13,055 |
|
|
|
9,636 |
|
|
|
5,924 |
|
Depreciation expense |
|
14,326 |
|
|
|
10,728 |
|
|
|
3,031 |
|
Other operating expenses |
|
29,023 |
|
|
|
14,002 |
|
|
|
5,449 |
|
Total costs and expenses |
|
96,879 |
|
|
|
72,882 |
|
|
|
22,407 |
|
Operating loss |
|
(90,867 |
) |
|
|
(68,635 |
) |
|
|
(22,407 |
) |
Other income (expense), net |
|
|
|
|
|
||||||
Finance costs, net |
|
(652 |
) |
|
|
(9,738 |
) |
|
|
35 |
|
Change in fair value of financial instruments |
|
58,311 |
|
|
|
17,983 |
|
|
|
9,637 |
|
Loss on extinguishment of debt |
|
— |
|
|
|
(37,216 |
) |
|
|
(9,240 |
) |
Other income, net |
|
1,140 |
|
|
|
1,069 |
|
|
|
594 |
|
Total other income (expense), net |
|
58,799 |
|
|
|
(27,902 |
) |
|
|
1,026 |
|
Loss before income tax |
|
(32,068 |
) |
|
|
(96,537 |
) |
|
|
(21,381 |
) |
Income tax (expense) benefit |
|
(4,573 |
) |
|
|
232 |
|
|
|
(148 |
) |
Net loss available to common stockholders |
$ |
(36,641 |
) |
|
$ |
(96,305 |
) |
|
$ |
(21,529 |
) |
Other comprehensive loss |
|
|
|
|
|
||||||
Foreign currency translation loss, net of tax |
|
(226 |
) |
|
|
(86 |
) |
|
|
— |
|
Comprehensive loss |
$ |
(36,867 |
) |
|
$ |
(96,391 |
) |
|
$ |
(21,529 |
) |
|
|
|
|
|
|
||||||
Basic loss per share for the period attributable to common stockholders |
$ |
(0.44 |
) |
|
$ |
(5.78 |
) |
|
$ |
(1.34 |
) |
Basic weighted-average common shares outstanding |
|
83,188,276 |
|
|
|
16,655,634 |
|
|
|
16,029,826 |
|
Diluted loss per share for the period attributable to common stockholders |
$ |
(0.66 |
) |
|
$ |
(5.78 |
) |
|
$ |
(1.34 |
) |
Diluted weighted-average common shares outstanding |
|
83,798,149 |
|
|
|
16,655,634 |
|
|
|
16,029,826 |
|
|
|||||||
CONSOLIDATED BALANCE SHEETS |
|||||||
|
|
||||||
(in thousands of |
2022 |
|
2021 |
||||
ASSETS |
|
|
|
||||
Current assets |
|
|
|
||||
Cash and cash equivalents |
$ |
76,528 |
|
|
$ |
8,533 |
|
Restricted cash |
|
126 |
|
|
|
— |
|
Accounts receivable, net of allowance of |
|
1,388 |
|
|
|
1,196 |
|
Prepaid expenses and other current assets |
|
3,198 |
|
|
|
2,695 |
|
Total current assets |
|
81,240 |
|
|
|
12,424 |
|
Property and equipment, net |
|
47,981 |
|
|
|
32,530 |
|
Operating lease right-of-use assets |
|
8,171 |
|
|
|
2,955 |
|
Deferred income tax assets |
|
— |
|
|
|
1,640 |
|
Other non-current assets |
|
6,463 |
|
|
|
369 |
|
Total assets |
$ |
143,855 |
|
|
$ |
49,918 |
|
LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) |
|
|
|
||||
Current liabilities |
|
|
|
||||
Accounts payable |
$ |
9,850 |
|
|
$ |
6,650 |
|
Debt |
|
— |
|
|
|
108,473 |
|
Warrant liabilities |
|
8,335 |
|
|
|
143,237 |
|
Earnout liabilities |
|
1,353 |
|
|
|
— |
|
Operating lease liabilities |
|
2,176 |
|
|
|
985 |
|
Contract liabilities |
|
1,941 |
|
|
|
935 |
|
Accrued expenses and other liabilities |
|
6,417 |
|
|
|
23,435 |
|
Total current liabilities |
|
30,072 |
|
|
|
283,715 |
|
Operating lease liabilities |
|
6,063 |
|
|
|
2,083 |
|
Contract liabilities |
|
1,000 |
|
|
|
1,000 |
|
Other non-current liabilities |
|
522 |
|
|
|
2,552 |
|
Total liabilities |
|
37,657 |
|
|
|
289,350 |
|
Commitments and contingencies (Note 20) |
|
|
|
||||
Redeemable preferred stock, |
|
— |
|
|
|
21,306 |
|
Stockholders' equity (deficit) |
|
|
|
||||
Preferred stock, |
|
— |
|
|
|
— |
|
Common stock, |
|
— |
|
|
|
— |
|
|
|
(8,603 |
) |
|
|
(170,949 |
) |
Additional paid-in capital |
|
337,928 |
|
|
|
96,471 |
|
Accumulated other comprehensive loss |
|
(312 |
) |
|
|
(86 |
) |
Accumulated deficit |
|
(222,815 |
) |
|
|
(186,174 |
) |
Total stockholders’ equity (deficit) |
|
106,198 |
|
|
|
(260,738 |
) |
Total liabilities, redeemable preferred stock and stockholders' equity (deficit) |
$ |
143,855 |
|
|
$ |
49,918 |
|
|
|||||||||||
CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||||||
|
Year Ended |
||||||||||
(in thousands of |
2022 |
|
2021 |
|
2020 |
||||||
Cash flows from operating activities: |
|
|
|
|
|
||||||
Net loss |
$ |
(36,641 |
) |
|
$ |
(96,305 |
) |
|
$ |
(21,529 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
||||||
Depreciation expense |
|
14,326 |
|
|
|
10,728 |
|
|
|
3,031 |
|
Operating lease expense |
|
2,015 |
|
|
|
548 |
|
|
|
298 |
|
Deferred tax expense (benefit) |
|
1,601 |
|
|
|
(1,619 |
) |
|
|
(38 |
) |
Stock-based compensation |
|
8,368 |
|
|
|
10,881 |
|
|
|
1,732 |
|
Interest expense |
|
1,693 |
|
|
|
9,703 |
|
|
|
43 |
|
Change in fair value of financial instruments |
|
(58,311 |
) |
|
|
(17,983 |
) |
|
|
(9,637 |
) |
Loss on debt extinguishment |
|
— |
|
|
|
37,216 |
|
|
|
9,240 |
|
Expenses related to Merger |
|
9,859 |
|
|
|
— |
|
|
|
— |
|
Foreign exchange differences |
|
(4,578 |
) |
|
|
(2,385 |
) |
|
|
(1,507 |
) |
Loss on disposal of property and equipment and right of use assets |
|
996 |
|
|
|
579 |
|
|
|
372 |
|
Bad debt expense |
|
1,736 |
|
|
|
1,794 |
|
|
|
— |
|
Changes in operating assets and liabilities: |
|
|
|
|
|
||||||
Accounts receivable |
|
(1,928 |
) |
|
|
(4,691 |
) |
|
|
(221 |
) |
Prepaid expenses and other current assets |
|
(1,855 |
) |
|
|
21 |
|
|
|
(14 |
) |
Accounts payable |
|
(3,202 |
) |
|
|
1,421 |
|
|
|
6,474 |
|
Contract liabilities |
|
1,006 |
|
|
|
480 |
|
|
|
455 |
|
Accrued expenses and other liabilities |
|
(1,562 |
) |
|
|
21,622 |
|
|
|
497 |
|
Operating lease liabilities |
|
(1,985 |
) |
|
|
(449 |
) |
|
|
(370 |
) |
Net cash used in operating activities |
|
(68,462 |
) |
|
|
(28,439 |
) |
|
|
(11,174 |
) |
Cash flows from investing activities: |
|
|
|
|
|
||||||
Acquisitions of property and equipment |
|
(27,252 |
) |
|
|
(11,233 |
) |
|
|
(15,787 |
) |
Equity investment in OS |
|
(3,653 |
) |
|
|
— |
|
|
|
— |
|
Other |
|
53 |
|
|
|
3 |
|
|
|
14 |
|
Net cash used in investing activities |
|
(30,852 |
) |
|
|
(11,230 |
) |
|
|
(15,773 |
) |
Cash flows from financing activities: |
|
|
|
|
|
||||||
Proceeds from issuance of redeemable Series X preferred stock |
|
— |
|
|
|
20,332 |
|
|
|
— |
|
Proceeds from issuance of debt |
|
— |
|
|
|
7,513 |
|
|
|
17,348 |
|
Repurchase of stock |
|
(8,603 |
) |
|
|
— |
|
|
|
— |
|
Proceeds from exercise of Public Warrants |
|
5,291 |
|
|
|
— |
|
|
|
— |
|
Proceeds from sale of common stock |
|
167,504 |
|
|
|
— |
|
|
|
— |
|
Proceeds from exercise of stock options |
|
144 |
|
|
|
791 |
|
|
|
802 |
|
Net cash provided by financing activities |
|
164,336 |
|
|
|
28,636 |
|
|
|
18,150 |
|
Net increase in cash, cash equivalents and restricted cash |
|
65,022 |
|
|
|
(11,033 |
) |
|
|
(8,797 |
) |
Effect of foreign exchange rate changes |
|
4,237 |
|
|
|
2,299 |
|
|
|
1,507 |
|
Cash, cash equivalents and restricted cash - beginning of period |
|
8,533 |
|
|
|
17,267 |
|
|
|
24,557 |
|
Cash, cash equivalents and restricted cash - end of period |
$ |
77,792 |
|
|
$ |
8,533 |
|
|
$ |
17,267 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20230427005951/en/
Investor Relations:
(949) 491-8235
SATL@mzgroup.us
Media Relations:
pr@satellogic.com
Source: